跳至主要内容
临床试验/NCT01123291
NCT01123291已完成4 期

Randomized Evaluation of Routine Follow-up Coronary Angiography After Percutaneous Coronary Intervention Trial

Takeshi Morimoto2 个研究点 分布在 1 个国家目标入组 700 人开始时间: 2010年5月1日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
700
试验地点
2
主要终点
a composite of death/myocardial infarction/stroke/emergency hospitalization for acute coronary syndrome/hospitalization for congestive heart failure

研究概览

简要总结

The purpose of this study is to evaluate the long term clinical impact of routine follow-up coronary angiography after percutaneous coronary intervention (PCI). The primary endpoint is a composite of death/myocardial infarction/stroke/emergency hospitalization for acute coronary syndrome/hospitalization for congestive heart failure at 3-year after percutaneous coronary intervention.

详细描述

Routine follow-up coronary angiography after percutaneous coronary intervention has been performed to detect restenosis in a lot of PCI centers in Japan. On the other hand, previous studies reported that routine follow-up coronary angiography might lead to unnecessary reinterventions in asymptomatic patients. In this situation, the effect of routine follow-up coronary angiography on long-term clinical outcomes remains unknown. The purpose of this study is to evaluate the long-term clinical impact of routine follow-up coronary angiography after PCI compared with clinical follow-up alone. The primary endpoint of this study is a composite of death/myocardial infarction/stroke/emergency hospitalization for acute coronary syndrome/hospitalization for congestive heart failure at three-year after percutaneous coronary intervention. The design of this study is almost all-comer design enrolling patients received PCI without any exclusion criteria.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients received percutaneous coronary intervention
  • Patients older than 20 years old
  • Patients who will not scheduled any staged percutaneous coronary intervention

排除标准

  • 未提供

结局指标

主要结局

a composite of death/myocardial infarction/stroke/emergency hospitalization for acute coronary syndrome/hospitalization for congestive heart failure

时间窗: 4.8 years

a composite of death/myocardial infarction/stroke/emergency hospitalization for acute coronary syndrome/hospitalization for congestive heart failure

次要结局

  • hospitalization for congestive heart failure(4.8 years)
  • cardiac death(4.8 years)
  • myocardial infarction(4.8 years)
  • death(4.8 years)
  • clinically-driven target-lesion revascularization(4.8 years)
  • angina(4.8 years)
  • stroke(4.8 years)
  • composite of cardiac death, myocardial infarction or acute coronary syndrome(4.8 years)
  • stent thrombosis(4.8 years)
  • bleeding complications(4.8 years)
  • any coronary revascularization(4.8 years)
  • clinically-driven coronary revascularization(4.8 years)
  • any target-lesion revascularization(4.8 years)
  • coronary artery bypass grafting(4.8 years)
  • renal function(4.8 years)
  • emergency hospitalization for acute coronary syndrome(4.8 years)
  • clinically-driven follow-up coronary angiography(4.8 years)
  • follow-up coronary angiography(4.8 years)

研究者

发起方
Takeshi Morimoto
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Takeshi Morimoto

Professor

Kyoto University, Graduate School of Medicine

研究点 (2)

Loading locations...

相似试验